BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dubey SK, Lakshmi KK, Krishna KV, Agrawal M, Singhvi G, Saha RN, Saraf S, Saraf S, Shukla R, Alexander A. Insulin mediated novel therapies for the treatment of Alzheimer's disease. Life Sci 2020;249:117540. [PMID: 32165212 DOI: 10.1016/j.lfs.2020.117540] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Trobec T, Sepčić K, Žužek MC, Kladnik J, Podjed N, Cardoso Páscoa C, Turel I, Frangež R. Fine Tuning of Cholinesterase and Glutathione-S-Transferase Activities by Organoruthenium(II) Complexes. Biomedicines 2021;9:1243. [PMID: 34572429 DOI: 10.3390/biomedicines9091243] [Reference Citation Analysis]
2 Jamshidnejad-Tosaramandani T, Kashanian S, Babaei M, Al-Sabri MH, Schiöth HB. The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro. Pharmaceuticals (Basel) 2021;14:1136. [PMID: 34832918 DOI: 10.3390/ph14111136] [Reference Citation Analysis]
3 Wang H, Lu J, Zhao X, Qin R, Song K, Xu Y, Zhang J, Chen Y. Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures. Neurol Sci 2021. [PMID: 34550494 DOI: 10.1007/s10072-021-05616-1] [Reference Citation Analysis]
4 A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A. Nose-to-brain drug delivery for the treatment of Alzheimer's Disease: Current advancements and challenges. Expert Opin Drug Deliv 2022. [PMID: 35040728 DOI: 10.1080/17425247.2022.2029845] [Reference Citation Analysis]
5 Som Chaudhury S, Sinha K, Das Mukhopadhyay C. Intranasal route: The green corridor for Alzheimer's disease therapeutics. Journal of Drug Delivery Science and Technology 2021;66:102791. [DOI: 10.1016/j.jddst.2021.102791] [Reference Citation Analysis]
6 Mani V, Arfeen M, Mohammed HA, Elsisi HA, Sajid S, Almogbel Y, Aldubayan M, Dhanasekaran M, Alhowail A. Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic transmission: In vivo and molecular modeling studies. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.03.016] [Reference Citation Analysis]
7 Agrawal M, Prathyusha E, Ahmed H, Dubey SK, Kesharwani P, Singhvi G, Naidu VGM, Alexander A. Biomaterials in treatment of Alzheimer's disease. Neurochem Int 2021;145:105008. [PMID: 33684545 DOI: 10.1016/j.neuint.2021.105008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Ajazuddin, Alexander A. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother 2021;141:111919. [PMID: 34328108 DOI: 10.1016/j.biopha.2021.111919] [Reference Citation Analysis]
9 Dubey SK, Bhatt T, Agrawal M, Saha RN, Saraf S, Saraf S, Alexander A. Application of chitosan modified nanocarriers in breast cancer. Int J Biol Macromol 2022;194:521-38. [PMID: 34822820 DOI: 10.1016/j.ijbiomac.2021.11.095] [Reference Citation Analysis]
10 Zuliani I, Lanzillotta C, Tramutola A, Barone E, Perluigi M, Rinaldo S, Paone A, Cutruzzolà F, Bellanti F, Spinelli M, Natale F, Fusco S, Grassi C, Di Domenico F. High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer's Disease Signatures. Int J Mol Sci 2021;22:3746. [PMID: 33916835 DOI: 10.3390/ijms22073746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang B, Gao Y, Zhang X, Jiang J, Ren J, Wang S, Hu H, Zhao Y, Chen L, Zhao K, Dai F. Ultra-stable dextran conjugated prodrug micelles for oxidative stress and glycometabolic abnormality combination treatment of Alzheimer's disease. Int J Biol Macromol 2022;203:430-44. [PMID: 35093435 DOI: 10.1016/j.ijbiomac.2022.01.154] [Reference Citation Analysis]
12 Zheng M, Wang P. Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer's disease. 3 Biotech 2021;11:179. [PMID: 33927970 DOI: 10.1007/s13205-021-02738-3] [Reference Citation Analysis]
13 Safa N, Trobec T, Holland DC, Slazak B, Jacobsson E, Hawkes JA, Frangež R, Sepčić K, Göransson U, Moodie LWK, Robertson LP. Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from Papaver setiferum. J Nat Prod 2021. [PMID: 34910498 DOI: 10.1021/acs.jnatprod.1c00980] [Reference Citation Analysis]
14 Kaur J, Gulati M, Kapoor B, Jha NK, Gupta PK, Gupta G, Chellappan DK, Devkota HP, Prasher P, Ansari MS, Aba Alkhayl FF, Arshad MF, Morris A, Choonara YE, Adams J, Dua K, Singh SK. Advances in designing of polymeric micelles for biomedical application in brain related diseases. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109960] [Reference Citation Analysis]
15 Mani V, Arfeen M, Sajid S, Almogbel Y. Aqueous Ajwa dates seeds extract improves memory impairment in type-2 diabetes mellitus rats by reducing blood glucose levels and enhancing brain cholinergic transmission. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2021.12.060] [Reference Citation Analysis]
16 Poustforoosh A, Nematollahi MH, Hashemipour H, Pardakhty A. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.015] [Reference Citation Analysis]
17 Esmaeili Y, Yarjanli Z, Pakniya F, Bidram E, Los MJ, Eshraghi M, Klionsky DJ, Ghavami S, Zarrabi A. Targeting autophagy, oxidative stress, and ER stress for neurodegenerative diseases treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.001] [Reference Citation Analysis]
18 Krishna KV, Saha RN, Dubey SK. Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ 1–42 Induced Alzheimer’s Disease Rat Model. ACS Chem Neurosci 2020;11:4139-51. [DOI: 10.1021/acschemneuro.0c00430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Keller LA, Merkel O, Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res 2021. [PMID: 33491126 DOI: 10.1007/s13346-020-00891-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
20 Miziak B, Błaszczyk B, Czuczwar SJ. Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease. Pharmaceuticals (Basel) 2021;14:458. [PMID: 34068096 DOI: 10.3390/ph14050458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, Kesharwani P, Ravichandiran V, Kumar P, Naidu VGM, Murty US, Ajazuddin, Alexander A. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release 2020;327:235-65. [PMID: 32739524 DOI: 10.1016/j.jconrel.2020.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
22 Ke J, Tian Q, Xu Q, Fu Z, Fu Q. Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment. Drug Discov Today 2021;26:1991-2002. [PMID: 33962036 DOI: 10.1016/j.drudis.2021.04.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kioussis B, Tuttle CSL, Heard DS, Kennedy BK, Lautenschlager NT, Maier AB. Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review. Ageing Res Rev 2021;67:101302. [PMID: 33609776 DOI: 10.1016/j.arr.2021.101302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]